Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000710572 | SCV000840814 | benign | not provided | 2018-02-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002317938 | SCV000849879 | likely benign | Inborn genetic diseases | 2018-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV002253578 | SCV001015305 | benign | KBG syndrome | 2023-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000710572 | SCV001866927 | benign | not provided | 2020-05-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253578 | SCV002525163 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710572 | SCV004143429 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | ANKRD11: BP4, BS1 |
Prevention |
RCV003965459 | SCV004785437 | benign | ANKRD11-related condition | 2020-01-13 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |